Dimerizing agents, their production and use

Details Dimerizing agents, their production and use Dimerizing agents, their production and use

2006-01-10

2006-01-10

Huang, Evelyn Mei (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S291000, C540S456000, C540S455000

Reexamination Certificate

active

06984635

ABSTRACT:
Materials and methods are disclosed for regulation of biological events such as target gene transcription and growth, proliferation or differentiation of engineered cells.

REFERENCES:
patent: 4797368 (1989-01-01), Carter et al.
patent: 5139941 (1992-08-01), Muzyczka et al.
patent: 5173414 (1992-12-01), Lebkowski et al.
patent: 5252479 (1993-10-01), Srivastava
patent: 5310903 (1994-05-01), Goulet
patent: 5314471 (1994-05-01), Brauker et al.
patent: 5340903 (1994-08-01), Tetart et al.
patent: 5354678 (1994-10-01), Lebkowski et al.
patent: 5362718 (1994-11-01), Skotnicki
patent: 5373014 (1994-12-01), Failli et al.
patent: 5378836 (1995-01-01), Kao et al.
patent: 5387680 (1995-02-01), Nelson
patent: 5429821 (1995-07-01), Dorian et al.
patent: 5436146 (1995-07-01), Shenk et al.
patent: 5454935 (1995-10-01), Magaraggia
patent: 5525610 (1996-06-01), Caufield
patent: 5527907 (1996-06-01), Or
patent: 5583139 (1996-12-01), Or et al.
patent: 5658776 (1997-08-01), Flotte et al.
patent: WO 92/19595 (1992-11-01), None
patent: WO 93/13663 (1993-07-01), None
patent: WO 93/24641 (1993-12-01), None
patent: WO 94/02136 (1994-02-01), None
patent: WO 94/18207 (1994-08-01), None
patent: WO 94/18317 (1994-08-01), None
patent: WO 94/28938 (1994-12-01), None
patent: WO 95/02684 (1995-01-01), None
patent: WO 95/04521 (1995-02-01), None
patent: WO 95/16691 (1995-06-01), None
patent: WO 95/33052 (1995-12-01), None
patent: WO 96/06111 (1996-02-01), None
patent: WO 96/13597 (1996-05-01), None
patent: WO 96/20951 (1996-07-01), None
patent: WO 96/26285 (1996-08-01), None
patent: WO 96/39350 (1996-12-01), None
patent: WO 96/41865 (1996-12-01), None
patent: WO 97/02358 (1997-01-01), None
patent: WO 97/08298 (1997-03-01), None
patent: WO 97/31899 (1997-09-01), None
patent: WO 98/02441 (1998-01-01), None
Aebischer, P. et al. “Functional Recovery in Hemiparkinsonian Primates Transplanted with Polymer-Encapsulated PC12 Cells”Experimental Neurology126(2):151-158 (1994).
Aitken, A. et al. “Idenitification of the NH2-Terminal Blocking Group of Calcineurin B as Myristic Acid” FEBSLetters150(2):314-318 (Dec. 1982).
Ao, Z. et al. “Microencapsulation Improves Canine Islet Survival In Vivo” et al.Transplantation Proceedings27(6):3349-3350 (Dec. 1995).
Behringer, R.R. et al. “Dwarf Mice Produced by Genetic Ablation of Growth Hormone-Expressing Cells”Genes&Development2:453-461 (1988).
Belshaw et al. “Controlling Protein Association and Subcellular Localization with a Synthetic Ligand That Induces Heterodimerizationof Proteins”Proc. Natl. Acad. Sci. U.S.A.93:4604-4607 (May 1996).
Borelli, E. et al. “Targeting of an Inducible Toxic Phenotype in Animal Cells”Proc. Natl. Acad. Sci. U.S.A.85:7572-7576 (Oct. 1988).
Breitman, M.L. et al. “Genetic Ablation in Transgenic Mice with an Attenuated Diphtheria Toxin A Gene”Molecular and Cellular Biology10:474-476 (Feb. 1990).
Breitman, M.L. et al. “Genetic Ablation: Targeted Expression of a Toxin Gene Causes Microphtalmia in Transgenic Mice”Science238:1563-1565 (Dec. 1987).
Brown, E.J. et al. “A Mammalian Protein Targeted by G1-Arresting Rapamycin-Receptor Complex”Nature369:756-758 (Jun. 1994).
Caldwell, R.C. and Joyce, G.F. “Randomization of Genes by PCR Mutagenesis”PCR Methods and Applications2:28-33 (1992).
Carr, S.A. et al “n-Tetradecanoyl is the NH2-Terminal Blocking Group of the Catalytic Subunit of Cyclic AMP-Dependent Protein Kinase from Bovine Cardiac Muscle”Proc. Natl. Acad. Sci. U.S.A.79:6128-6131 (Oct. 1982.
Carter et al. “Adeno-Associated Virus Vectors”Current Opin. In Biotech.3:533-539 (1992).
Chaffin, K.E. et al. “Dissection of Thymocyte Signaling Pathways by In Vivo Expression of Pertussis Toxin ADP-Ribosyltransferase”The EMBO Journal9(12):3821-3829 (1990).
Chang, P.L. et al. “Delivery of Recominbant Gene Products with Microencapsulated Cells In Vivo”Human Gene Therapy4:433-440 (1993).
Chen, J. “Identification of an 11-kDa FKBP12-rapamycin-binding Domain Within the 289-kDa FKBP12-rapamycin-associated Protein and Characterization of a Critical Serine Residue”Proc. Natl. Acad. Sci. U.S.A.92:4947-4951 (May 1995).
Chiu, M.I. et al. “RAPT1, a Mammalian Homolog of Yeast Tor, Interacts with the FKBP12/Rapamycin Complex”Proc. Natl. Acad. Sci. U.S.A.91:12574-12578 (Dec. 1994).
Clackson, T. and Wells, J.A. “In Vitro Selection from Protein and Peptide Libraries”TIBTECH12:173-184 (May 1994).
Crameri, A. et al. “Construction and Evolution of Antibody-Phage Libraries by DNA Shuffling”Nature Medicine2(1):100-103 (Jan. 1996).
Cunningham, B.C. and Wells, J.A. “High-Resolution Epitope Mapping of hGH-Receptor Interactions by Alanine-Scanning Mutagenesis”Science244:1081-1085 (Jun. 1989).
Dennis, M.S. and Lazarus, R.A. “Kunitz Domain Inhibitors of Tissue Factor-Factor VIIa”Journal of Biological Chemistry269(35)22129-22136 (1994).
Dubensky, T.W. et al. “Direct Transfection of Viral and Plasmid DNA into the Liver of Spleen of Mice”Proc. Natl. Acad. Sci. U.S.A.81:7529-7533 (Dec. 1984).
Emerich, D.F. et al. “Intrastriatal Implants of Polymer-Encapsulated PC12 Cells” Effects on Motor Function in Aged RatsProg. Neuro-Psychopharmacol.&Biol. Psychiat.18:935-946 (1994).
Emrich, D.F. et al. “Polymer-Encapsulated PC12 Cells Promote Recovery of Motor Functionin Aged Rats”Experimental Neurology122:37-47 (1993).
Ferry, N. et al. “Retroviral-Mediated Gene Transfer into Hepatocytes In Vivo”Proc. Natl. Acad. Sci. U.S.A.88:8377-8381 (Oct. 1991).
Fields, S. and Song, O-k “A Novel Genetic System to Detect Protein-Protein Interactions”Nature340:245-246 (Jul. 1989).
Fisher, K.J. et al. “Recombinant Adenovirus Deleted of All Viral Genes for Gene Therapy of Cystic Fibrosis”Virology217:11-22 (1996).
Flotte et al. “Expression of the Cystic Fibrosis Transmembrane Conductance Regulator from a Novel Adeno-Associated Virus Promoter”The Journal of Biological Chemistry268(5):3781-3790 (1993).
Goldman, M.J. et al. “Transfer of the CFTR Gene to the Lung of Nonhuman Primates with E1-Deleted, E2a-Defective Recombinant Adenoviruses: A Preclinical Toxicology Study”Human Gene Therapy6:839-851 (Jul. 1995).
Hatzogluo, M. et al. “Hepatic Gene Transfer in Animals Using Retroviruses Containing the Promoter From the Gene for Phosphoenolpyruvate Carboxykinase”J. Biol. Chem.265(28):17285-17293 (1990).
Henderson, L.E. et al. “Myristyl Amino-Terminal Acylation of Murine Retrovirus proteins: An Unusual Post-Translational Protein Modification”Proc. Natl. Acad. Sci. U.S.A.80:339-343 (Jan. 1983).
Heyman, R.A. et al. “Thymidine Kinase Obliteration: Creation of Transgenic Mice with Controlled Immune Deficiency”Proc. Natl. Acad. Sci. U.S.A.86:2698-2702 (Apr. 1989).
Hiebert, S.W. et al. “E1A-Dependent Trans-Activation of the Human MYC Promoter is Mediated by the E2F Factor”Proc. Natl. Acad. Sci. U.S.A.86:3594-3598 (May 1989).
Ho, S.N. et al. “Dimeric Ligands Define a Role for Transcriptional Activation Domains in Reinitiation”Nature382:822-826 (Aug. 1996).
Holsinger, L.J. et al. “Signal transduction in T Lymphocytes Using a Conditional Allele of Sos”Proc. Natl. Acad. Sci. U.S.A.92:9810-9814 (Oct. 1995).
Hu, J.C. “Repressor Fusions as a Tool to Study Protein-Protein Interactions”Structure3:431-433 (May 1995).
Hu, J.C. et al. “Sequence Requirements for Coiled-Coils: Analysis with λ Repressor-GCN4 Leucine Zipper Fusions”Science250: 1400-1403 (Dec. 1990).
Joyner, A.L. et al. “Production of a Mutation in Mouse EN-2 Gene by Homologous Recombination in Embryonic Stem Cells”Nature338:153-156 (Mar. 1989).
Kaneda, Y et al. “Increased Expression of DNA Cointroduced with Nuclear Protein in Adult Rat Liver”Science243:375-3

Affiliated with

Also associated with

Rating

Dimerizing agents, their production and use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dimerizing agents, their production and use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dimerizing agents, their production and use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3525885